Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study
Jakacki, Regina I., Foley, Margaret A., Horan, Julie, Wang, Jiuzhou, Kieran, Mark W., Bowers, Daniel C., Bouffet, Eric, Zacharoulis, Stergios, Gill, Stan C.
Published in Journal of neuro-oncology (01.08.2016)
Published in Journal of neuro-oncology (01.08.2016)
Get full text
Journal Article
Juvenile toxicity study of faropenem medoxomil in beagle puppies
Faqi, Ali S., Lanphear, Chery, Gill, Stan, Colagiovanni, Dorothy B.
Published in Reproductive toxicology (Elmsford, N.Y.) (01.12.2010)
Published in Reproductive toxicology (Elmsford, N.Y.) (01.12.2010)
Get full text
Journal Article
Phase I Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor in Patients with Refractory Solid Tumors
BEUTEL, Gernot, GLEN, Hilary, SCHÖFFSKI, Patrick, CHICK, Jon, GILL, Stan, CASSIDY, James, TWELVES, Chris
Published in Clinical cancer research (01.08.2005)
Published in Clinical cancer research (01.08.2005)
Get full text
Journal Article
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Perl, Alexander E, MD, Altman, Jessica K, MD, Cortes, Jorge, MD, Smith, Catherine, MD, Litzow, Mark, MD, Baer, Maria R, MD, Claxton, David, Prof, Erba, Harry P, Prof, Gill, Stan, PhD, Goldberg, Stuart, MD, Jurcic, Joseph G, Prof, Larson, Richard A, Prof, Liu, Chaofeng, PhD, Ritchie, Ellen, MD, Schiller, Gary, MD, Spira, Alexander I, MD, Strickland, Stephen A, MD, Tibes, Raoul, MD, Ustun, Celalettin, MD, Wang, Eunice S, Prof, Stuart, Robert, Prof, Röllig, Christoph, MD, Neubauer, Andreas, Prof, Martinelli, Giovanni, Prof, Bahceci, Erkut, MD, Levis, Mark, Dr
Published in The lancet oncology (01.08.2017)
Published in The lancet oncology (01.08.2017)
Get full text
Journal Article
Antitumor Efficacy, Pharmacokinetics, and Biodistribution of NX 211: A Low-Clearance Liposomal Formulation of Lurtotecan
EMERSON, D. L, BENDELE, R, MOYNIHAN, K, RICHARDSON, F. C, TOMKINSON, B, LUZZIO, M. J, BACCANARI, D, BROWN, E, SUMING CHIANG, DESJARDINS, J. P, DIHEL, L. C, GILL, S. C, HAMILTON, M, LERAY, J. D, MOON-MCDERMOTT, L
Published in Clinical cancer research (01.07.2000)
Get full text
Published in Clinical cancer research (01.07.2000)
Journal Article
Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia
Smith, Catherine Choy, Levis, Mark J., Litzow, Mark Robert, Perl, Alexander E., Altman, Jessica K., Gill, Stan, Yuen, Geoffrey, Bonate, Peter, Kadokura, Takeshi, James, Angela Joubert, Liu, Charles, Nagase, Itsuro, Fisniku, Ogert, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Selective Inhibition of FLT3 by Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia: a Multicenter, First-in-human, Open-label, Phase 1/2 Study
Perl, Alexander E., Altman, Jessica K., Cortes, Jorge, Smith, Catherine, Litzow, Mark, Baer, Maria R., Claxton, David, Erba, Harry P., Gill, Stan, Goldberg, Stuart, Jurcic, Joseph G., Larson, Richard A., Liu, Chaofeng, Ritchie, Ellen, Schiller, Gary, Spira, Alexander I., Strickland, Stephen A., Tibes, Raoul, Ustun, Celalettin, Wang, Eunice S., Stuart, Robert, Röllig, Christoph, Neubauer, Andreas, Martinelli, Giovanni, Bahceci, Erkut, Levis, Mark
Published in The lancet oncology (20.06.2017)
Published in The lancet oncology (20.06.2017)
Get full text
Journal Article
Common and rare EGFR mutations ( EGFR m) in the RADIANT trial: Final follow-up with 5 year data
Shepherd, Frances A., Eberhardt, Wilfried Ernst Erich, Altorki, Nasser K., O'Brien, Mary E.R., Wang, Joe, Wu, Jun, Gill, Stan, Iwata, Kenneth, Richardson, Frank C, Horan, Julie D., Foley, Margaret A., Kelly, Karen
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Results of a first-in-human, phase I/II trial of ASP2215, a selective, potent inhibitor of FLT3/Axl in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML)
Levis, Mark J., Perl, Alexander E., Altman, Jessica K., Cortes, Jorge E., Ritchie, Ellen K., Larson, Richard A., Smith, Catherine Choy, Wang, Eunice S., Strickland, Stephen Anthony, Baer, Maria R., Litzow, Mark Robert, Claxton, David, Schiller, Gary J., Ustun, Celalettin, Liu, Charles, Gill, Stan, Sargent, Briana, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A drug-drug interaction study between adefovir dipivoxil and lamivudine, acetaminophen, ibuprofen and trimethoprim/sulfamethoxazole
Kearney, Brian, Knight, Wanda, Currie, Graeme, Contreras, Jennifer, Wolf, John, Gill, Stan, Fry, John, Brosgart, Carol
Published in Journal of hepatology (01.04.2002)
Published in Journal of hepatology (01.04.2002)
Get full text
Journal Article
Adefovir dipivoxil safety and pharmacokinetics in subjects with hepatitis B virus infection and in healthy subjects
Kearney, Brian, Knight, Wanda, Currie, Graeme, Beutelspacher, Desiree, Ebrahimi, Ramin, Gill, Stan, Fry, John, Brosgart, Carol
Published in Journal of hepatology (01.04.2002)
Published in Journal of hepatology (01.04.2002)
Get full text
Journal Article
Dosing guidelines for Adefovir Dipivoxil in the treatment of HBV infected patients with renal or hepatic impairment
Knight, Wanda, Hayashi, Sandra, Benhamou, Yves, Currie, Graeme, Ebrahimi, Ramin, Gill, Stan, Fry, John, Kearney, Brian, Brosgart, Carol
Published in Journal of hepatology (2002)
Published in Journal of hepatology (2002)
Get full text
Journal Article